Published : 01 Aug 2025
Aagami met its past Belgian client during BIO 2025 in Boston. Thereafter, now we have received a new out-licensing assignment from Belgian client.
The client has engaged Aagami to explore business opportunities with companies that may be interested in entering into a commercial arrangement, and without diminishing the generality of the foregoing, such arrangements may include licensing, and other forms of partnering with respect to the client’s technologies, specially two (2) Technologies below:
1. Selection Technology using Bacteriocin-Immunity to Improve Microbial Fermentation
2. Bacteriocins applications for the control of contaminants in industrial fermentation
If you are interested to know more for Licensing consideration, please contact us.